Healthcare


 CSL Shares Rise 15% in 5 Weeks as Two Hedge Funds Make Opposing Bets

CSL Shares Rise 15% in 5 Weeks as Two Hedge Funds Make Opposing Bets

December 05, 2023 12:59 AM AEDT| By Team Kalkine Media

The CSL Limited (,ASX: CSL,) share price is presently trading at $264.35, indicating a marginal 0.07% increase in midday trading on Tuesday. This follows a period of volatility for CSL shares in 2023, characterized by reaching a four-year low of $228...

 CSL Share Price Surges, Tripling ASX 200 Return in November

CSL Share Price Surges, Tripling ASX 200 Return in November

December 01, 2023 05:44 PM AEDT| By Team Kalkine Media

In November 2023, the CSL Limited (,ASX: CSL,) share price experienced a remarkable upswing, outperforming the S&P/ASX 200 Index with a notable 13% gain compared to the index's 4.5% rise. Despite this positive momentum, the CSL share price remains mo...

 Why is the Mesoblast Share Price in a Trading Halt?

Why is the Mesoblast Share Price in a Trading Halt?

December 01, 2023 03:25 PM AEDT| By Team Kalkine Media

The Mesoblast Ltd (ASX: MSB) share price is currently in a trading halt as the biotechnology company plans to undertake another capital raising. The trading halt is expected to remain in effect until Tuesday, December 5, pending an announcement relat...

 Ramsay Health Care (ASX: RHC) shares plummet amid brokers' concerns over French business

Ramsay Health Care (ASX: RHC) shares plummet amid brokers' concerns over French business

November 29, 2023 11:35 AM AEDT| By Team Kalkine Media

The Australian healthcare sector witnessed a notable event as Ramsay Health Care's (,ASX: RHC,) shares experienced a downturn, falling by as much as 1.9% to AU$48.39, in the morning hours on 29 November 2023. This marks the lowest point since 30 Octo...

 Why Are Mesoblast Shares Surging 5% Today?

Why Are Mesoblast Shares Surging 5% Today?

November 28, 2023 09:54 PM AEDT| By Team Kalkine Media

Mesoblast Ltd (,ASX: MSB,) is witnessing a noteworthy uptick in its share price, registering a 5% increase to 42 cents in early afternoon trade. This positive movement is a notable development for the biotechnology company in the current session. How...

 Pro Medicus (ASX: PME): A Phenomenal Surge of 784% in ASX 200 Healthcare in last 5 years

Pro Medicus (ASX: PME): A Phenomenal Surge of 784% in ASX 200 Healthcare in last 5 years

November 27, 2023 01:35 AM AEDT| By Team Kalkine Media

e Pro Medicus Ltd (ASX: PME) healthcare share has yet again marked a surge, currently trading at AU$89.21 from AU$88.59 at yesterday's close. With a staggering 784% rise in five years and a recent surge of 64% in 2023, investors are curious about the...

 CSL Shares: Aiming for $300 by Christmas?

CSL Shares: Aiming for $300 by Christmas?

November 17, 2023 10:33 PM AEDT| By Team Kalkine Media

The CSL Limited (ASX: CSL) share price, reflecting the challenges in recent months, closed at $258.21, experiencing a 0.9% decline for the day. This,ASX healthcare stock,encountered a new 52-week low of $228.65 in late October. However, the past few...

 Sonic Healthcare Ltd (ASX: SHL) Set to Acquire Pathology Watch: An Insight Into the ASX 200 Healthcare Stock

Sonic Healthcare Ltd (ASX: SHL) Set to Acquire Pathology Watch: An Insight Into the ASX 200 Healthcare Stock

November 16, 2023 01:49 PM AEDT| By Team Kalkine Media

In recent market updates, the S&P/ASX 200 Index witnessed fluctuations, particularly in the healthcare sector, as Sonic Healthcare Ltd (,ASX: SHL,) announced its plans for a significant acquisition. Amidst these developments, the share price of Sonic...

 Sonic Healthcare Ltd (ASX: SHL) Faces Decline After Announcing $200 Million US Acquisition

Sonic Healthcare Ltd (ASX: SHL) Faces Decline After Announcing $200 Million US Acquisition

November 16, 2023 07:15 AM AEDT| By Team Kalkine Media

The giant,ASX-listed healthcare stocks,, Sonic Healthcare Ltd, is currently witnessing a decline in its share price, a movement that outpaces the broader ASX 200. The shares, which closed at $30.50, have fallen 4.6% to $29.09 at the time of writing....

 Why Did Goldman Sachs Upgrade CSL Shares?

Why Did Goldman Sachs Upgrade CSL Shares?

November 15, 2023 07:59 PM AEDT| By Team Kalkine Media

Goldman Sachs has recently upgraded the giant,ASX healthcare stock,, CSL Limited (ASX: CSL) shares, suggesting that the current market conditions provide a compelling entry point after a multiple de-rate. The upgrade is based on the biotherapeutics g...

 4DMedical Ltd Shares Surge 67% as U.S. Medicare Recognition Fuels Investor Excitement

4DMedical Ltd Shares Surge 67% as U.S. Medicare Recognition Fuels Investor Excitement

November 13, 2023 05:11 PM AEDT| By Team Kalkine Media

In a remarkable start to the week,,shares,of 4DMedical Ltd (,ASX: 4DX,) have experienced a surge of 67%, reaching 77 cents in afternoon trade on the Australian Securities Exchange (ASX). The medical technology company's stock has witnessed substantia...

 Pro Medicus Shares Reach Record High on Lucrative U.S. Contract with Oregon Health & Science University

Pro Medicus Shares Reach Record High on Lucrative U.S. Contract with Oregon Health & Science University

November 13, 2023 02:47 PM AEDT| By Team Kalkine Media

In a remarkable surge, shares of Pro Medicus Limited (,PME.AX,) reached an all-time high, rising by as much as 1.8% to A$86.750. The healthcare services provider's stock is poised for its best day since November 7, pending the sustainability of these...

 Race Oncology Ltd (ASX: RAC) Shares Surge on Positive Phase 2 Trial Results

Race Oncology Ltd (ASX: RAC) Shares Surge on Positive Phase 2 Trial Results

November 07, 2023 10:28 PM AEDT| By Team Kalkine Media

The Race Oncology Ltd (,ASX: RAC,) share price has garnered significant investor interest on Tuesday, surging by 16% in morning trading to reach $1.05 per share. This impressive uptick is a direct response to a positive announcement from the,ASX heal...

 Imugene Share Price Surges 10%: Here's Why

Imugene Share Price Surges 10%: Here's Why

November 06, 2023 04:56 PM AEDT| By Team Kalkine Media

The,ASX healthcare stocks,like Imugene Ltd (ASX: IMU) share price has experienced a notable surge, rising by 10.4% as of the current trading session. This surge is attributed to Imugene's announcement of a positive update from an ongoing clinical tri...

 CSL Share Price 'Most Attractive' in Uncertain Times, Says Fund Manager

CSL Share Price 'Most Attractive' in Uncertain Times, Says Fund Manager

November 02, 2023 07:28 PM AEDT| By Team Kalkine Media

The CSL Ltd (ASX: CSL) share price is standing out among,ASX healthcare stocks,during the current market rally. CSL shares closed at $234.98 and have since risen to $237.63, marking a 1.1% gain in line with the broader 1.2% increase in the ASX 200 at...

 Pro Medicus shares sport a P/E ratio above 100. Is this overly expensive?

Pro Medicus shares sport a P/E ratio above 100. Is this overly expensive?

October 30, 2023 06:46 PM AEDT| By Team Kalkine Media

In the ever-evolving landscape of the stock market, one company has been making headlines for its extraordinary performance. Pro Medicus Ltd (,ASX: PME,) has seen its shares soar, with a remarkable 40% increase in 2023 and an astounding 630% surge ov...

 ResMed's 36 % Share price Drop: CEO Assesses Ozempic and GLP-1 Impact

ResMed's 36 % Share price Drop: CEO Assesses Ozempic and GLP-1 Impact

October 27, 2023 05:50 PM AEDT| By Team Kalkine Media

ResMed Inc (ASX: RMD) has recently reported its 1Q FY24 results, with a 36% share price drop in the past six months. While the financials appear robust, concerns about the impact of Ozempic and GLP-1 medications on ResMed's business have raised inves...

 An insider recently acquired more CSL shares; should you follow suit?

An insider recently acquired more CSL shares; should you follow suit?

October 24, 2023 10:33 PM AEDT| By Team Kalkine Media

CSL Limited (,ASX: CSL,), one of Australia's leading healthcare companies, has faced challenges in recent months, resulting in a decline in its share price. Concerns over a slower margin recovery and the emergence of Ozempic as a potential treatment...

 Citi predicts ResMed shares could increase by 70% in the next 12 months

Citi predicts ResMed shares could increase by 70% in the next 12 months

October 24, 2023 09:36 PM AEDT| By Team Kalkine Media

While several,ASX healthcare stocks,have experienced fluctuations in their share prices, ResMed Inc. (ASX: RMD) recently faced a 2% dip, trading at $22.90 during Tuesday's afternoon session. This decline might represent a compelling buying opportunit...

 ASX Healthcare Stocks Surge: Immutep Ltd Gains 16% on 'Promising' Results

ASX Healthcare Stocks Surge: Immutep Ltd Gains 16% on 'Promising' Results

October 23, 2023 05:57 PM AEDT| By Team Kalkine Media

The,ASX healthcare stocks,sector is witnessing an exciting development as Immutep Ltd (ASX: IMM) shares surge by 16% in morning trade to reach 32 cents. What's behind this significant increase in the ASX All Ords biotech stock's value?,Investors are...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.